Psychedelics in Psychiatry 

Abstract

Psychedelics are being studied intensely these years, namely for non-psychotic mental health conditions. In this talk clinical and neuromechanistic data will be presented from psychedelic studies in addiction, depression and healthy volunteers. 

Biography

Dr David Erritzoe is a psychiatrist and neuroscientist. Since 2009 he has conducted & overseen psychopharmacological and clinical research into the effects and brain mechanisms of psychedelics at Imperial College. Here he holds a Clinical Senior Lectureship (i.e. assistant professorship) in Psychiatry in Division of Psychiatry’s Centre Psychedelic Research where he is also the Clinical Director. From early 2021 he is heading a new NHS-based psychopharmacology & psychedelic  research clinic at St Charles Hospital, the CIPPRes Clinic.